Large-Scale Validated Antibodies for Immunohistochemistry
The key to successful IHC is: Know your antibody!
MS Validated Antibodies offers:
Extensive validation process on tissues
Extremely sophisticated product selection (only 130 approved products out of 4000 candidates)
Protocol recommendations
Documented performance characteristics of many antibodies in studies involving more than 10,000 tumors
Why is antibody validation different for antibodies in formalin fixed immunohistochemistry?
Formalin fixation exerts a profound impact on the three-dimensional structure of proteins and the accessibility of epitopes.
Because formalin changes the proteins, traditional methods for evaluating antibodies on
unfixed "perfect" proteins (WB, ELISA, protein microarrays) will not distinguish good and bad antibodies for IHC.
MS Validated Antibodies Specificity
Large Scale Studies Publications with MSVA Antibodies on >10.000 tumors
SAVE THE DATE - You can find us and MS Validated Antibodies at the following workshop:
"The Future of Pathology Researchis Digital: New Challenges and Old Friends"
February 29th - March 1st, 2024
OpenZone, Open Lamp, Conference Room Via Lillo De Luca 10 - 20091 Bresso (Milan) - Italy
